Nefazodone Hydrochloride

NEFAZODONE-D5 HCL; 3H-1,2,4-Triazol-3-one, 2-3-4-(3-chlorophenyl)-1-piperazinylpropyl-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, monohydrochloride; Nefazodone HCl; Nefazodone hydrochloride; NEFAZODONE; BMY-13754, MJ-13754-1, Serzone, 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl- 2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride; 2,4-Dihydro-2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-5-ethyl-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride; Nefazodone hydrochlo;Nefazodone hydrochloride;1-(3-(4-(m-Chlorophenyl)-1-piperazinyl)propyl)-3-ethyl-4-(2-phenoxyethyl)-delta(sup 2)-1,2,4-triazolin-5-one monohydrochloride; 3H-1,2,4-Triazol-3-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl))propyl)-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, monohydrochloride; BMY 13754; Dutonin; Menfazona; MJ 13,754-1; Nefazodone HCl; Nefazodone hydrochloride; Reseril; Rulivan; Serzone; UNII-27X63J94GR; Systematic Name 3H-1,2,4-Triazol-3-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, monohydrochloride; Registry Numbers CAS Registry Number 82752-99-6;FDA UNII 27X63J94GR;Related Registry Number 83366-66-9 (Parent);System Generated Number 0082752996; Molecular Formulas ?Molecular Formula C25-H32-Cl-N5-O2.Cl-H;Molecular Formula Fragments C25-H32-Cl-N5-O2; Cl-H; COMPONENT;